McMillan Office’s Aehr Test Systems AEHR Stock Holding History

McMillan Office’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.92K	Buy	+20	New	+$1.83K	﹤0.01%	463

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

McMillan Office's AEHR Position: Q2 2026 in Review

McMillan Office opened a new position in Aehr Test Systems (AEHR) in Q2 2026: 20 shares worth $1.92K. The stake represents ﹤0.01% of the portfolio and ranks #463 among its holdings.

262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

McMillan Office held 20 shares of Aehr Test Systems worth $1.92K as of Q2 2026.
Aehr Test Systems was a new McMillan Office position in Q2 2026.
Aehr Test Systems made up ﹤0.01% of McMillan Office's portfolio in Q2 2026, its #463 holding.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.